Because neutrophils from SLE patients displayed a strong “IFN signature”, it is tempting to speculate that their increased capacity to produce IL-6 likely depends on previous in vivo exposures to circulating type I IFN, thus consistent with in vitro experiments. Here, IFNA1 is linked to systemic lupus erythematosus.